EDGAR Filing Documents for 0001511164-17-000106

Form 8-K - Current report:

SEC Accession No. 0001511164-17-000106

Filing Date

2017-03-09

Accepted

2017-03-09 16:48:41

Documents

Period of Report

2017-03-03

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	form8k3717ppmclosingbiotrici.htm	8-K	33432
2	FORM OF WARRANT	f41.htm	EX-4.1	39542
3	FORM OF PLACEMENT AGENTS WARRANTS	f42.htm	EX-4.2	40436
4	INVESTMENT BANKING AGREEMENT, AS AMENDED	f101.htm	EX-10.1	58390
5	FORM OF SUBSCRIPTION AGREEMENT	f102.htm	EX-10.2	222850
6	FORM OF PROMISSORY NOTE	f103.htm	EX-10.3	19765
	Complete submission text file	0001511164-17-000106.txt		416025

Mailing Address 75 INTERNATIONAL BLVD., SUITE 300 TORONTO A6 M9W 6L9

Business Address 75 INTERNATIONAL BLVD., SUITE 300 TORONTO A6 M9W 6L9 (416) 214-3678

BIOTRICITY INC. (Filer) CIK: 0001630113 (see all company filings)